Wells Fargo analyst Steve Baxter maintained a Hold rating on Cigna (CI – Research Report) on December 15 and set a price target of $334.00. The company’s shares closed last Friday at $290.50.
According to TipRanks, Baxter is an analyst with an average return of -1.0% and a 50.48% success rate. Baxter covers the Healthcare sector, focusing on stocks such as Humana, Cigna, and Tenet Healthcare.
In addition to Wells Fargo, Cigna also received a Hold from Deutsche Bank’s George Hill in a report issued on December 12. However, on December 15, Bank of America Securities maintained a Buy rating on Cigna (NYSE: CI).
See the top stocks recommended by analysts >>
The company has a one-year high of $329.97 and a one-year low of $237.19. Currently, Cigna has an average volume of 1.96M.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Cigna (CI) Company Description:
Founded in 1792, Cigna Corporation is a Connecticut-based global health services company, which provides insurance and related products and services. It operates through the following segments: Health Services, Integrated Medical, International Markets, and Group Disability and Other.
Read More on CI:
- Elevance, HCSC vying for Cigna’s Medicare Advantage unit, Bloomberg says
- Elevance, HCSC vying for Cigna Medicare Advantage unit, Bloomberg says
- Zillow upgraded, Airbnb downgraded: Wall Street’s top analyst calls
- Cigna price target raised by $4 at Deutsche Bank
- Humana upgraded to Buy from Hold at Argus
